New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S617

Introduced

1/9/24

Introduced

1/13/26

Refer

1/9/24

Refer

1/13/26

Caption

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

Latest NJ S617 Activity

View All Events: NJ 2024-2025 Regular Session S617

Companion Bills

NJ A998

Same As Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ A2119

Carry Over Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ S2155

Carry Over Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ S211

Carry Over Requires insurers offering commercial general liability insurance policies to provide notification of exclusion for communicable disease.

Previously Filed As

NJ S1865

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ A4494

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

NJ HB3767

Controlled dangerous substances; adding certain substances to Schedules I and IV; effective date.

NJ S322

Establishes tianeptine as Schedule II controlled dangerous substance.

NJ HB1311

Controlled dangerous substances; adding chemicals to Schedule I; effective date.

NJ HB1311

Controlled dangerous substances; adding chemicals to Schedule I; effective date.

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.

NJ SB860

Uniform Controlled Dangerous Substances Act; adding certain substance to Schedule I. Effective date.

NJ SB860

Uniform Controlled Dangerous Substances Act; adding certain substance to Schedule I. Effective date.

NJ AR26

Urges Congress to deschedule marijuana as Schedule I controlled substance under federal "Controlled Substances Act."

Similar Bills

No similar bills found.